Search results for "View"

showing 10 items of 5786 documents

Usability of the testing criteria for English proficiency in competence tests : assessor perceptions

2010

Tutkimuksen tarkoituksena on selvittää arvioijien näkemyksiä englannin kielen taidon arvioimiseen laadittujen näyttökriteerien käytettävyydestä hotellivirkailijan ja matkailun ohjelmapalvelujen ammattitutkinnoissa. Ilman ammatillista pätevyyttä pitkään työssä olleet aikuiset voivat hankkia ammattitutkinnon Suomessa osoittamalla ammattitaitonsa näyttötutkintojen avulla. Näyttöä vastaanottava oppilaitos laatii näyttökriteerit tutkinnon perusteissa määriteltyjen arviointikriteerien pohjalta. Tarkastelun kohteina tässä tutkimuksessa eivät ole vain arvioijien yleiset näkemykset näyttökriteerien käytöstä pitkällä aikavälillä, vaan myös heidän mielipiteensä hyödyllisistä ja hyödyttömistä kriteerei…

näyttökokeetkriteeritcontent analysisCompetence-based Qualificationshotellialainterviewlanguage testingassessor perceptionsenglannin kielimatkailuala
researchProduct

Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)…

2021

Most anticancer molecules are administered in body-size-based dosing schedules, bringing up unsolved issues regarding pharmacokinetic data in heavy patients. The worldwide spread of obesity has not been matched by improved methods and strategies for tailored drug dosage in this population. The weight or body surface area (BSA)-based approaches may fail to fully reflect the complexity of the anthropometric features besides obesity in cancer patients suffering from sarcopenia. Likewise, there is a lack of pharmacokinetic data on obese patients for the majority of chemotherapeutic agents as well as for new target drugs and immunotherapy. Therefore, although the available findings point to the …

obesityCancer Researchmedicine.medical_specialtypharmacokinetic parametersConsensusBSAcancer drug dosingPopulationchemotherapy doseAntineoplastic AgentsReviewOverweightNODosing schedulesNeoplasmsPhysiciansInternal medicineHumansMedicineDosingLS4_3educationBody surface areaeducation.field_of_studybusiness.industryCancerCytotoxic chemotherapymedicine.diseaseOncologyBSA; cancer drug dosing; chemotherapy dose; obesity; pharmacokinetic parametersPosition paperBSA; cancer drug dosing; chemotherapy dose; obesity; pharmacokinetic parameters; Consensus; Humans; Obesity; Antineoplastic Agents; Neoplasms; Physiciansmedicine.symptombusinessESMO Open
researchProduct

The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium

2021

Adipose tissue (AT) biology is linked to cardiovascular health since obesity is associated with cardiovascular disease (CVD) and positively correlated with excessive visceral fat accumulation. AT signaling to myocardial cells through soluble factors known as adipokines, cardiokines, branched-chain amino acids and small molecules like microRNAs, undoubtedly influence myocardial cells and AT function via the endocrine-paracrine mechanisms of action. Unfortunately, abnormal total and visceral adiposity can alter this harmonious signaling network, resulting in tissue hypoxia and monocyte/macrophage adipose infiltration occurring alongside expanded intra-abdominal and epicardial fat depots seen …

obesityEndocrinology Diabetes and MetabolismAdipokineAdipose tissueAdipose tissueMyocardiocytesInflammationContext (language use)ReviewBioinformaticsDiseases of the endocrine glands. Clinical endocrinologyCoronary artery diseasechemistry.chemical_compoundEndocrinologyAdipocytemicrobiotamedicineHumansMyocytes CardiacMyocardial infarctionObesityInflammationbusiness.industryMyocardiumMicrobiotaRC648-665medicine.diseaseCor MalaltiesmyocardiocytesAdipose TissuechemistryObesitatmedicine.symptombusinessDysbiosisSignal Transduction
researchProduct

Diet to Reduce the Metabolic Syndrome Associated with Menopause. The Logic for Olive Oil

2020

The rates of metabolic syndrome are increasing in parallel with the increasing prevalence of obesity, primarily due to its concomitant insulin resistance. This is particularly concerning for women, as the years around menopause are accompanied by an increase in visceral obesity, a strong determinant of insulin resistance. A fall in estrogens and increase in the androgen/estrogen ratio is attributed a determining role in this process, which has been confirmed in other physiological models, such as polycystic ovary syndrome. A healthy lifestyle, with special emphasis on nutrition, has been recommended as a first-line strategy in consensuses and guidelines. A consistent body of evidence has ac…

obesityMediterranean dietmedicine.drug_classmenopausePhysiologylcsh:TX341-641030209 endocrinology & metabolismReviewDisease030204 cardiovascular system & hematologyDiet Mediterraneanmetabolic syndromeHealthy Aging03 medical and health sciences0302 clinical medicineInsulin resistanceHumansMedicineNutritional Physiological PhenomenaHealthy LifestyleAgedNutrition and Dieteticsbusiness.industryEstrogensMiddle Agedolive oilmedicine.diseasePolycystic ovaryObesityMenopauseEstrogenObesity AbdominalAndrogensFemalewomenDiet HealthyInsulin ResistanceMetabolic syndromehealthy ageingbusinesslcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Impact of Obesity in Kidney Diseases.

2021

The clinical consequences of obesity on the kidneys, with or without metabolic abnormalities, involve both renal function and structures. The mechanisms linking obesity and renal damage are well understood, including several effector mechanisms with interconnected pathways. Higher prevalence of urinary albumin excretion, sub-nephrotic syndrome, nephrolithiasis, increased risk of developing CKD, and progression to ESKD have been identified as being associated with obesity and having a relevant clinical impact. Moreover, renal replacement therapy and kidney transplantation are also influenced by obesity. Losing weight is key in limiting the impact that obesity produces on the kidneys by reduc…

obesityNutrition and DieteticsNutrition. Foods and food supplybariatric surgeryfatty kidneyReviewurologic and male genital diseasesKidney TransplantationglomerulopathyRisk FactorsCKDHumansTX341-641Kidney DiseasesESRDDialysisFood ScienceNutrients
researchProduct

Innovations in Infant Feeding: Future Challenges and Opportunities in Obesity and Cardiometabolic Disease

2020

The field of nutrition in early life, as an effective tool to prevent and treat chronic diseases, has attracted a large amount of interest over recent years. The vital roles of food products and nutrients on the body’s molecular mechanisms have been demonstrated. The knowledge of the mechanisms and the possibility of controlling them via what we eat has opened up the field of precision nutrition, which aims to set dietary strategies in order to improve health with the greatest effectiveness. However, this objective is achieved only if the genetic profile of individuals and their living conditions are also considered. The relevance of this topic is strengthened considering the importance of …

obesityPediatric ObesityInfants AlimentacióRevieweating behaviorGenetic profile0302 clinical medicineNutrigenomicsPregnancy030212 general & internal medicinePrecision MedicineChildprecision nutritionPediatriaNutrition and DieteticsNutrigenomicsCardiovascular DiseasesChild PreschoolObesitatFemaleDiet HealthyChild Nutritional Physiological Phenomenalcsh:Nutrition. Foods and food supplypediatricsAdolescentNutritional Statuslcsh:TX341-641030209 endocrinology & metabolismChildhood obesityNutrigenetics03 medical and health sciencesEnvironmental healthmedicinemicrobiotaHumansMetabolomicsGenetic Predisposition to DiseaseInfant feedingnutrigeneticsbusiness.industryInfant NewbornInfantFeeding Behaviormedicine.diseaseCardiometabolic diseaseObesitycardiometabolic risk factorsGastrointestinal MicrobiomeFood productsAvaluació del riscbusinessFood ScienceNutrients
researchProduct

COVID Obesity: A One-Year Narrative Review

2021

On 11 March 2020, coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO). This study focuses on a narrative review about the illness during the first year of the pandemic in relation to obesity. Databases were used to search studies published up to 8 December 2020. In total, 4430 articles and other scientific literature were found, and 24 articles were included in this one-year narrative review. The mean BMI value of severe COVID-19 patients ranged from 24.5 to 33.4 kg/m2, versus 2 for non-severe patients. Articles using the terms obesity or overweight without indicating the BMI value in these patients were common, but this is not useful, as the a…

obesityReviewComorbidityScientific literature030204 cardiovascular system & hematologyOverweightSeverity of Illness IndexCOVID obesityBody Mass IndexBMI03 medical and health sciences0302 clinical medicinePandemicSeverity of illnessHumansoverweightMedicineTX341-641030212 general & internal medicineEpidemiologiaPandemicsNutrition and DieteticsSARS-CoV-2Nutrition. Foods and food supplybusiness.industryCOVID-19Anthropometrymedicine.diseaseObesityComorbiditynutritionTrastorns de la nutricióObesitatmedicine.symptombusinessBody mass indexFood ScienceDemographyNutrients
researchProduct

Lihavuus terveyden, sairauden ja normaaliuden määrittelyn kohteena

2018

Lihavuudesta ja lihavasta ruumiista on tullut viimeistään viime vuosikymmenen niin kutsutun lihavuusepidemiadiskurssin myötä keskeinen paitsi lääketieteellisen myös sosiaalisen ja moraalisen arvioinnin, yhteiskunnallisen keskustelun ja toimintaohjelmien kohde. Tässä katsausartikkelissa tarkastellaan ruumiin koon ja erityisesti lihavuuden määrittelyä. Artikkelissa eritellään ruumiin koon ja koon määrittelyn taustoja ja perusteita, ruumiin kokoon ja painoon liittyvää valtarakenteita, tiedontuotantoa, kulttuurisia ja sosiaalisia tekijöitä, ja niiden vaikutuksia. Artikkelissa lihavuuden normalisaatiopyrkimykset kytketään medikalisaatiokehitykseen, terveysaatteeseen ja uusliberaaliin eetokseen. …

obesitylcsh:GN1-890lcsh:History (General) and history of Europeneoliberalismlcsh:Anthropologyreview articlelcsh:GR1-950uusliberalismilcsh:History (General)health ideaslcsh:D1-2009katsausartikkelilcsh:Folkloremedikalisaatioterveysaatelcsh:DlihavuusmedicalizationJ@rgonia
researchProduct

Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials

2021

Intermittent fasting has become popular in recent years and is controversially presented as a possible therapeutic adjunct. A bibliographic review of the literature on intermittent fasting and obesity, diabetes, and multiple sclerosis was carried out. The scientific quality of the methodology and the results obtained were evaluated in pairs. Intermittent fasting has beneficial effects on the lipid profile, and it is associated with weight loss and a modification of the distribution of abdominal fat in people with obesity and type 2 diabetes as well as an improvement in the control of glycemic levels. In patients with multiple sclerosis, the data available are too scarce to draw any firm con…

obesitymedicine.medical_specialtyMultiple SclerosisGlycemic ControlReviewType 2 diabeteslaw.inventionRandomized controlled trialWeight losslawDiabetes mellitusIntermittent fastingHumansMedicineTX341-641Intensive care medicineRandomized Controlled Trials as TopicGlycemicNutrition and Dieteticsexercisemedicine.diagnostic_testNutrition. Foods and food supplyintermittent fastingbusiness.industryFastingmedicine.diseaseObesityDiabetes Mellitus Type 2type 2 diabetesmedicine.symptombusinessLipid profileFood ScienceNutrients
researchProduct

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

2013

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, including elevated sdLDL levels, in addition to elevated triglycerides (TG), very low density lipoprotein (VLDL) and apolipoprotein-B, as well as decreased high density lipoprotein cholesterol (HDL-C) levels. Obesity-related co-morbidities, such as metabolic syndrome (MetS) are also characterized by dyslipidaemia. Therefore, agents that favourably modulate LDL subclasses may be of clinical value in t…

obesitymedicine.medical_specialtyVery low-density lipoproteinLipoproteinslipid-lowering drugsanti-obesity drugslcsh:TX341-641030209 endocrinology & metabolismReview030204 cardiovascular system & hematologyOverweight03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinInternal medicineHumansMedicineRisk factorDyslipidemiasMetabolic Syndromeobesity treatmentNutrition and Dieteticssmall dense low density lipoproteinbusiness.industryCholesterollipoproteinmedicine.disease3. Good healthEndocrinologychemistryCardiovascular DiseasesLow-density lipoproteinlipids (amino acids peptides and proteins)Metabolic syndromemedicine.symptombusinesslcsh:Nutrition. Foods and food supplyanti-obesity drugFood ScienceLipoproteinNutrients
researchProduct